72 related articles for article (PubMed ID: 26952881)
1. Breast Cancer Resistance Protein Abundance, but Not mRNA Expression, Correlates With Estrone-3-Sulfate Transport in Caco-2.
Harwood MD; Neuhoff S; Rostami-Hodjegan A; Warhurst G
J Pharm Sci; 2016 Apr; 105(4):1370-5. PubMed ID: 26952881
[TBL] [Abstract][Full Text] [Related]
2. Expression, localization, and functional characteristics of breast cancer resistance protein in Caco-2 cells.
Xia CQ; Liu N; Yang D; Miwa G; Gan LS
Drug Metab Dispos; 2005 May; 33(5):637-43. PubMed ID: 15716365
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Drug Transport in MDCKII-Wild Type, MDCKII-MDR1, MDCKII-BCRP and Caco-2 Cell Lines.
Mukkavilli R; Jadhav G; Vangala S
Curr Pharm Biotechnol; 2017; 18(14):1151-1158. PubMed ID: 29521222
[TBL] [Abstract][Full Text] [Related]
4. Silencing the breast cancer resistance protein expression and function in caco-2 cells using lentiviral vector-based short hairpin RNA.
Zhang W; Li J; Allen SM; Weiskircher EA; Huang Y; George RA; Fong RG; Owen A; Hidalgo IJ
Drug Metab Dispos; 2009 Apr; 37(4):737-44. PubMed ID: 19131524
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer resistance protein BCRP (ABCG2)-mediated transepithelial nitrofurantoin secretion and its regulation in human intestinal epithelial (Caco-2) layers.
Wright JA; Haslam IS; Coleman T; Simmons NL
Eur J Pharmacol; 2011 Dec; 672(1-3):70-6. PubMed ID: 22004608
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer resistance protein exports sulfated estrogens but not free estrogens.
Imai Y; Asada S; Tsukahara S; Ishikawa E; Tsuruo T; Sugimoto Y
Mol Pharmacol; 2003 Sep; 64(3):610-8. PubMed ID: 12920197
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Breast Cancer Resistance Protein (BCRP/ABCG2) on Drug Transport Across Caco-2 Cell Monolayers.
Kawahara I; Nishikawa S; Yamamoto A; Kono Y; Fujita T
Drug Metab Dispos; 2020 Jun; 48(6):491-498. PubMed ID: 32193356
[TBL] [Abstract][Full Text] [Related]
8. In-vitro evidence of enhanced breast cancer resistance protein-mediated intestinal urate secretion by uremic toxins in Caco-2 cells.
Lu Y; Nakanishi T; Hosomi A; Komori H; Tamai I
J Pharm Pharmacol; 2015 Feb; 67(2):170-7. PubMed ID: 25515305
[TBL] [Abstract][Full Text] [Related]
9. Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein.
Liu H; Huang L; Li Y; Fu T; Sun X; Zhang YY; Gao R; Chen Q; Zhang W; Sahi J; Summerfield S; Dong K
Drug Metab Dispos; 2017 May; 45(5):449-456. PubMed ID: 28209803
[TBL] [Abstract][Full Text] [Related]
10. Efflux transporter breast cancer resistance protein dominantly expresses on the membrane of red blood cells, hinders partitioning of its substrates into the cells, and alters drug-drug interaction profiles.
Shi P; Liao M; Chuang BC; Griffin R; Shi J; Hyer M; Fallon JK; Smith PC; Li C; Xia CQ
Xenobiotica; 2018 Nov; 48(11):1173-1183. PubMed ID: 29098941
[TBL] [Abstract][Full Text] [Related]
11. Aconitum alkaloids, the major components of Aconitum species, affect expression of multidrug resistance-associated protein 2 and breast cancer resistance protein by activating the Nrf2-mediated signalling pathway.
Wu JJ; Zhu YF; Guo ZZ; Lou YM; He SG; Guan Y; Zhu LJ; Liu ZQ; Lu LL; Liu L
Phytomedicine; 2018 May; 44():87-97. PubMed ID: 29277460
[TBL] [Abstract][Full Text] [Related]
12. Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban.
Jacqueroux E; Hodin S; Saib S; He Z; Bin V; Delézay O; Delavenne X
Eur J Pharm Biopharm; 2020 Mar; 148():27-37. PubMed ID: 31945490
[TBL] [Abstract][Full Text] [Related]
13. Cobalt Chloride Induces Expression and Function of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Renal Proximal Tubular Epithelial Cell Line HK-2.
Nishihashi K; Kawashima K; Nomura T; Urakami-Takebayashi Y; Miyazaki M; Takano M; Nagai J
Biol Pharm Bull; 2017; 40(1):82-87. PubMed ID: 28049953
[TBL] [Abstract][Full Text] [Related]
14. Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists.
Ebert B; Seidel A; Lampen A
Carcinogenesis; 2005 Oct; 26(10):1754-63. PubMed ID: 15917307
[TBL] [Abstract][Full Text] [Related]
15. New insights into the carrier-mediated transport of estrone-3-sulfate in the Caco-2 cell model.
Grandvuinet AS; Gustavsson L; Steffansen B
Mol Pharm; 2013 Sep; 10(9):3285-95. PubMed ID: 23834246
[TBL] [Abstract][Full Text] [Related]
16. Sulfotransferases and Breast Cancer Resistance Protein Determine the Disposition of Calycosin in Vitro and in Vivo.
Yu J; Zhu L; Zheng H; Gong X; Jiang H; Chen J; Li Y; Zheng H; Qi X; Wang Y; Hu M; Lu L; Liu Z
Mol Pharm; 2017 Sep; 14(9):2917-2929. PubMed ID: 28445053
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence-Based Transport Assays Revisited in a Human Renal Proximal Tubule Cell Line.
Caetano-Pinto P; Janssen MJ; Gijzen L; Verscheijden L; Wilmer MJ; Masereeuw R
Mol Pharm; 2016 Mar; 13(3):933-44. PubMed ID: 26871298
[TBL] [Abstract][Full Text] [Related]
18. In Vitro-In Vivo Extrapolation Scaling Factors for Intestinal P-Glycoprotein and Breast Cancer Resistance Protein: Part I: A Cross-Laboratory Comparison of Transporter-Protein Abundances and Relative Expression Factors in Human Intestine and Caco-2 Cells.
Harwood MD; Achour B; Neuhoff S; Russell MR; Carlson G; Warhurst G;
Drug Metab Dispos; 2016 Mar; 44(3):297-307. PubMed ID: 26631742
[TBL] [Abstract][Full Text] [Related]
19. In Vitro-In Vivo Extrapolation Scaling Factors for Intestinal P-glycoprotein and Breast Cancer Resistance Protein: Part II. The Impact of Cross-Laboratory Variations of Intestinal Transporter Relative Expression Factors on Predicted Drug Disposition.
Harwood MD; Achour B; Neuhoff S; Russell MR; Carlson G; Warhurst G; Rostami-Hodjegan A
Drug Metab Dispos; 2016 Mar; 44(3):476-80. PubMed ID: 26842595
[TBL] [Abstract][Full Text] [Related]
20. Glyceollin Effects on MRP2 and BCRP in Caco-2 Cells, and Implications for Metabolic and Transport Interactions.
Chimezie C; Ewing A; Schexnayder C; Bratton M; Glotser E; Skripnikova E; Sá P; Boué S; Stratford RE
J Pharm Sci; 2016 Feb; 105(2):972-981. PubMed ID: 26296158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
